Presentation EuroPCR 2024

Site-specific antithrombotic therapy: DESyne BDS Plus study 12-month outcomes

Presenter: Alexandre Abizaid

May 14, 2024

REGISTER for free or LOG IN to view this content

Site-specific antithrombotic therapy: DESyne BDS Plus study 12-month outcomes

Coronary

DES/BRS/DCB

Presentation

EuroPCR 2024

Up Next

Presentation EuroPCR 2024

First report of an IDE pivotal study of a dedicated splitting device during TAVR

Presenter: Danny Dvir

May 15, 2024

More slides +

Presentation EuroPCR 2024

Is coronary artery bypass surgery cost-effective compared with contemporary PCI? A FAME 3 analysis

Presenter: Frederik Zimmermann

May 15, 2024

Presentation NY Valves 2024

Lessons From Off Label TAVR Use in Pure AR – Tips & Tricks

Presenter: Raj Makkar

June 05, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.